Canada · Delayed Price · Currency is CAD InnoCan Pharma Company Description
InnoCan Pharma Corporation operates as a pharmaceutical technology company in United States, Canada, Europe, and internationally.
The company operates through two segments: Pharmaceuticals and Consumer Wellness. The company's Pharmaceutical segment engages in the development of drug delivery technologies for both human and animal health applications, based on advanced cannabinoids science.
It offers a Cannabidiol-loaded Liposome injection Platform (LPT-CBD) that facilitates dosing and release of synthetic cannabidiol into the blood stream for the treatment of chronic pain.
The company's Consumer Wellness segment engages in the development and marketing of self-care and hemp-derived cannabidiol beauty products through the brand B.I.
Sky. Skincare and Beauty: Its skincare product range includes face creams, serums, masks, soaps, and neck creams for the treatment of dark spot, skin discoloration, hyperpigmentation, and anti-aging .
Its pain relief products includes cannabidiol-based topical treatments, such as pain relief sprays and roll-on formulations.
InnoCan Pharma Corporation was founded in 2017 and is headquartered in Calgary, Canada.
| Country | Canada |
| Founded | 2017 |
| Industry | Household & Personal Products |
| Sector | Consumer Staples |
| CEO | Iris Bincovich |
Contact Details
Address: 1015, 926 – 5 Avenue SW Calgary, AB T2P 0N7 Canada | |
| Phone | 516 210 4025 |
| Website | innocanpharma.com |
Stock Details
| Ticker Symbol | INNO |
| Exchange | Canadian Securities Exchange |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| ISIN Number | CA45783P1027 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Roni Kamhi | Chief Operating Officer, Chief Executive Officer of B.I. Sky Global LTD and Director |
| Iris Bincovich | Chief Executive Officer and Interim Chairwoman |
| Nelson Harvey Halpern F.C.A., FCPA | Chief Financial Officer |
| Eyal Flom L.L.M., M.B.A. | Company Secretary, General Counsel and Director |
| Dr. Eyal Kalo | Vice President of Research and Development |